What's Going On With Monopar Therapeutics Shares Friday? - Monopar Therapeutics ( NASDAQ:MNPR )
Monopar Therapeutics, Inc. MNPR shares are trading lower Friday after gaining on Thursday. The stock was volatile yesterday following the company's agreement with Alexion, AstraZeneca Rare Disease for an exclusive worldwide license to ALXN-1840 in regards to potentially treating Wilson disease.
| Ticker |
Sentiment |
Impact |
|
AZN
|
Bullish
|
25 %
|
|
BRK-A
|
Somewhat Bullish
|
9 %
|
|
MNPR
|
Somewhat Bullish
|
33 %
|
